---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-013473"
form_type: "8-K"
ticker: "OCUL"
cik: "0001393434"
company_name: "OCULAR THERAPEUTIX, INC"
filed_at: "2025-02-14T23:59:59+00:00"
generated_at: "2026-05-26T19:36:30.065878+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# CEO Dugel receives new compensation package with $819,200 salary, performance stock awards

## Summary
- Base salary raised to $819,200 annually; bonus target at 75% of salary; $368,100 2024 bonus plus $500,000 special one-time bonus.
- Time-Based RSU Award: 1,250,000 shares vesting over three years.
- Performance Awards: PSU up to 1,500,000 shares and Performance Option for 2,750,000 shares at $7.44 strike, tied to stock price hurdles from $15 to $30.
- Performance awards contingent on stockholder approval for 2021 Plan increase; no annual equity grant for 2026.
- Equity awards designed to align with long-term stockholder value; service-vesting through third anniversary.

## SEC filing metadata
- accession: 0001104659-25-013473
- form_type: 8-K
- ticker: OCUL
- cik: 0001393434
- company_name: OCULAR THERAPEUTIX, INC
- filed_at: 2025-02-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1393434/000110465925013473/0001104659-25-013473-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1393434/000110465925013473/tm256644d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-013473
- JSON: https://secwatch.observer/filing/0001104659-25-013473.json
- Plain text: https://secwatch.observer/filing/0001104659-25-013473.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.